引用本文:
本文已被:浏览 175次   下载 265
 
艾司西酞普兰与氟西汀对抑郁症患者疗效及血清 脑源性神经营养因子、炎性反应因子的影响
金玲
()
fszhuche.com:
目的 分析艾司西酞普兰与氟西汀治疗抑郁症患者临床疗效及对患者血清脑源性神经营 养因子(BDNF)、炎性反应因子的影响。方法 以2017 年1 月至2018 年11 月在我院精神科收治的抑郁 症患者118 例为研究对象,按照随机数字表法分为观察组59 例和对照组59 例,对照组患者采用氟西汀 治疗,观察组采用艾司西酞普兰治疗,两组均治疗6 周,观察治疗后两组临床疗效,比较治疗前后两组 血清BDNF、神经功能相关因子(S100B)及炎性反应因子[白细胞介素2、6(IL-2、IL-6)、肿瘤坏死因子α (TNF-α)]水平的变化,记录治疗前后汉密顿抑郁量表(HAMD)评分和不良反应量表(TESS)评分变化。 结果 观察组经艾司西酞普兰治疗后总有效率为86.44%,对照组经氟西汀治疗后总有效率为76.27%, 两组比较差异无统计学意义(χ2=2.011,P> 0.05);两组治疗后血清BDNF 水平与治疗前相比明显升高, S100B 水平下降(P< 0.01),观察组治疗后血清BDNF水平明显高于对照组(P< 0.01),而S100B 水平明显 低于对照组(P < 0.01)。两组治疗后IL-2、IL-6、TNF-α水平与治疗前相比明显降低,观察组治疗后各 炎性因子水平明显低于对照组(P< 0.01)。治疗3 周、6 周后两组HAMD 评分与治疗前相比均明显降低 (P< 0.01),在治疗3 周后观察组HAMD 评分明显低于对照组(P < 0.01),在治疗6 周后两组HAMD 评分 比较差异无统计学意义(P>0.05),观察组治疗期间TESS评分略低于对照组,但差异无统计学意义(P> 0.05)。结论 艾司西酞普兰与氟西汀治疗抑郁症均具有显著疗效,且安全性相当,相较于氟西汀,艾司 西酞普兰治疗后患者血清BDNF 明显升高,炎性因子水平明显降低,且起效快。
基金项目:
Effects of escitalopram and fluoxetine on depression and serum BDNF and inflammatory reactionfactor
()
Abstract:
Objectives To analyze the clinical efficacy of escitalopram and fluoxetine in the treatment of depression and the influence on serum brain-derived neurotrophic factor( BDNF) and inflammatory response factor. Methods A total of 118 patients with depression admitted to the psychiatric department of our hospital from January 2017 to November 2018 were recruited as the research subjects. All the subjects were assigned to observation group( n=59) and control group( n=59) by random number table method. The control group was treated with fluoxetine, while the observation group was treated with escitalopram. The treatment lasted for 6 weeks. The clinical effects of the two groups were observed after treatment, and the two groups were compared before and after on serum levels of BDNF, neurological function-related factor( S100B) and inflammatory reaction factors, including interleukin-2, 6( IL-2, IL-6) and tumor necrosis factor-alpha( TNF-α). The changes of Hamilton Depression Scale( HAMD) score and Treatment Emergent Symptom Scale( TESS) score were recorded before and after treatment. Results The total effective rate was 86.44% in the observation group and 76.27% in the control group. There was no statistical significance in the difference between the two groups( P> 0.05). After treatment, the level of serum BDNF increased significantly than before, while the level of S100B decreased( P<0.01). The level of BDNF of the observation group is higher than that of the control group, while the level of S100B is lower after treatment( P<0.01). After treatment, the levels of IL-2, IL-6 and TNF-α in the two groups were significantly lower than those before treatment. The levels of inflammatory factors in the observation group after treatment were significantly lower than those in the control group( P<0.01). After 3 and 6 weeks of treatment, HAMD scores in both groups were significantly lower than those before treatment( P<0.01). The HAMD score of the observation group was significantly lower than that of the control group after 3 weeks of treatment (P< 0.01), however, there was no significant difference in the HAMD score between the two groups after 6 weeks of treatment( P>0.05). The TESS score of the observation group was slightly lower than that of the control group during the treatment period, but there was no statistical significance( P>0.05). Conclusions Escitalopram and fluoxetine are both effective and safe in the treatment of depression. Compared with fluoxetine, the level of serum BDNF in patients treated with Escitalopram is significantly higher, the level of inflammatory factors is significantly lower and the effect is faster.

用微信扫一扫

用微信扫一扫